# The Immunogenicity and Persistence of Booster Dose With Hepatitis B Vaccine in College Students

> **NCT05099757** · PHASE4 · UNKNOWN · sponsor: **Shanxi Medical University** · enrollment: 150 (estimated)

## Conditions studied

- Hepatitis B Vaccine

## Interventions

- **BIOLOGICAL:** 20 µg dose hepatitis B vaccine

## Key facts

- **NCT ID:** NCT05099757
- **Lead sponsor:** Shanxi Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-20
- **Primary completion:** 2022-11-25
- **Final completion:** 2023-12-15
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2021-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05099757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05099757, "The Immunogenicity and Persistence of Booster Dose With Hepatitis B Vaccine in College Students". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05099757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*